318 related articles for article (PubMed ID: 19289595)
21. [Immunophenotyping of leukemic cells in the diagnosis of hairy cell leukemia].
Gotić M; Kraguljac N; RolovićZ ; Radosević N; Bosković D
Srp Arh Celok Lek; 2000; 128(5-6):157-64. PubMed ID: 11089415
[TBL] [Abstract][Full Text] [Related]
22. [Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry].
Hu Y; Chen Y; Wang LH; Chen X; Fang F; Liu SQ; Wu XQ; Zhu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):349-56. PubMed ID: 24763004
[TBL] [Abstract][Full Text] [Related]
23. CD5-negative, CD10-negative small B-cell leukemia: variant of chronic lymphocytic leukemia or a distinct entity?
Sheikh SS; Kallakury BV; Al-Kuraya KA; Meck J; Hartmann DP; Bagg A
Am J Hematol; 2002 Dec; 71(4):306-10. PubMed ID: 12447961
[TBL] [Abstract][Full Text] [Related]
24. [Differential malignant lymphoproliferative syndrome (LPS) diagnosis with flow cytometry: a study of 100 patients].
Cardile N; Sabo G; Butsch P; Brengarth E; Viollier AF; Knecht H
Praxis (Bern 1994); 2000 Jan; 89(4):143-9. PubMed ID: 10686807
[TBL] [Abstract][Full Text] [Related]
25. Paraneoplastic vasculitis associated with hairy cell leukemia.
Svecová D; Pallová A; Chmurová N; Babal P
Prague Med Rep; 2008; 109(1):83-7. PubMed ID: 19097393
[TBL] [Abstract][Full Text] [Related]
26. Hairy-cell leukemia variant: recent view on diagnosis, biology and treatment.
Robak T
Cancer Treat Rev; 2011 Feb; 37(1):3-10. PubMed ID: 20558005
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical Detection of Hairy Cell Leukemia in Paraffin Sections: The Role of Pax5 and CD103 Double Staining to Improve Specificity and Sensitivity.
Rozenvald IB; Richardson MD; Brock L; Maiese RL
Arch Pathol Lab Med; 2017 Jun; 141(6):837-840. PubMed ID: 28418282
[TBL] [Abstract][Full Text] [Related]
28. Histopathological audit of splenectomies received at a cancer hospital.
Gujral S; Lad P; Subramanian PG; Shet TM; Epari S; Laskar S; Muckaden M; Menon H; Sengar M; Nair R
Indian J Pathol Microbiol; 2011; 54(3):487-96. PubMed ID: 21934208
[TBL] [Abstract][Full Text] [Related]
29. Differential Expression of CD43, CD81, and CD200 in Classic Versus Variant Hairy Cell Leukemia.
Salem DA; Scott D; McCoy CS; Liewehr DJ; Venzon DJ; Arons E; Kreitman RJ; Stetler-Stevenson M; Yuan CM
Cytometry B Clin Cytom; 2019 Jul; 96(4):275-282. PubMed ID: 31077558
[TBL] [Abstract][Full Text] [Related]
30. Immunophenotyping and differential diagnosis of hairy cell leukemia.
Matutes E
Hematol Oncol Clin North Am; 2006 Oct; 20(5):1051-63. PubMed ID: 16990106
[TBL] [Abstract][Full Text] [Related]
31. CD27-positive hairy cell leukemia-Japanese variant.
Tabata R; Tabata C; Iwama H; Yasumizu R; Kojima M
Virchows Arch; 2016 Mar; 468(3):375-9. PubMed ID: 26868143
[TBL] [Abstract][Full Text] [Related]
32. Flow Cytometric Patterns of CD200 and CD1d Expression Distinguish CD10-Negative, CD5-Negative Mature B-Cell Lymphoproliferative Disorders.
Mason EF; Pozdnyakova O; Li B; Dudley G; Dorfman DM
Am J Clin Pathol; 2017 Jul; 148(1):33-41. PubMed ID: 28575142
[TBL] [Abstract][Full Text] [Related]
33. The CD45 isoform B220 identifies select subsets of human B cells and B-cell lymphoproliferative disorders.
Rodig SJ; Shahsafaei A; Li B; Dorfman DM
Hum Pathol; 2005 Jan; 36(1):51-7. PubMed ID: 15712182
[TBL] [Abstract][Full Text] [Related]
34. CD200 (OX-2 membrane glycoprotein) expression in b cell-derived neoplasms.
Dorfman DM; Shahsafaei A
Am J Clin Pathol; 2010 Nov; 134(5):726-33. PubMed ID: 20959655
[TBL] [Abstract][Full Text] [Related]
35. Blastic transformation of hairy cell leukemia.
Nazeer T; Burkart P; Dunn H; Jennings TA; Wolf B
Arch Pathol Lab Med; 1997 Jul; 121(7):707-13. PubMed ID: 9240906
[TBL] [Abstract][Full Text] [Related]
36. A Single-center Experience in Splenic Diffuse Red Pulp Lymphoma Diagnosis.
Julhakyan HL; Al-Radi LS; Moiseeva TN; Danishyan KI; Kovrigina AM; Glebova SM; Lugovskaya SA; Dvirnik VN; Khvastunova AN; Yakutik IA; Savchenko VG
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S166-9. PubMed ID: 27131623
[TBL] [Abstract][Full Text] [Related]
37. Hairy cell leukemia, a B-cell neoplasm that is particularly sensitive to the cytotoxic effect of anti-Tac(Fv)-PE38 (LMB-2).
Robbins DH; Margulies I; Stetler-Stevenson M; Kreitman RJ
Clin Cancer Res; 2000 Feb; 6(2):693-700. PubMed ID: 10690555
[TBL] [Abstract][Full Text] [Related]
38. Hairy cell leukemia: diagnostic pathology.
Sharpe RW; Bethel KJ
Hematol Oncol Clin North Am; 2006 Oct; 20(5):1023-49. PubMed ID: 16990105
[TBL] [Abstract][Full Text] [Related]
39. [Variant hairy-cell leukemia: immunophenotypic and ultrastructural study of a case].
Palomera L; García Díez I; Martínez García R
Sangre (Barc); 1991 Apr; 36(2):135-9. PubMed ID: 1866652
[TBL] [Abstract][Full Text] [Related]
40. Clinico-pathological profile of Hairy cell leukemia: critical insights gained at a tertiary care cancer hospital.
Galani KS; Subramanian PG; Gadage VS; Rahman K; Ashok Kumar MS; Shinde S; Mahadik S; Ansari R; Sengar M; Menon H; Nair R; Gujral S
Indian J Pathol Microbiol; 2012; 55(1):61-5. PubMed ID: 22499303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
